Cargando…

Efficacy of levosimendan in shock

Detalles Bibliográficos
Autores principales:	McLean, A, Huang, S, Stewart, D, Nalos, M, Tang, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099670/ http://dx.doi.org/10.1186/cc2550

Ejemplares similares

Levosimendan reduces pulmonary vascular resistance: clinical echocardiographic study
por: Nalos, M, et al.
Publicado: (2004)

Levosimendan versus dobutamine in septic shock
por: Alhashemi, JA, et al.
Publicado: (2009)

Effects of levosimendan and inhaled nitric oxide on microcirculation in septic shock
por: Morelli, A, et al.
Publicado: (2009)

Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF
por: McLean, AS, et al.
Publicado: (2003)

Interferon gamma levels are reduced by adenosine 5'-triphosphate in lipopolysaccharide-stimulated whole human blood
por: Nalos, M, et al.
Publicado: (2007)

Hemodynamic and echographic effects of levosimendan in patients with cardiogenic shock refractory to catecholamines
por: Labbene, I, et al.
Publicado: (2006)

Levosimendan in patients with acute cardiogenic shock, not responders to conventional therapy
por: Vetrugno, L, et al.
Publicado: (2007)

Effects of levosimendan in acute heart failure, cardiogenic and septic shock
por: Alhashemi, JA, et al.
Publicado: (2008)

Levosimendan therapy does not improve survival of post-resuscitation cardiogenic shock patients
por: Soos, P, et al.
Publicado: (2009)

Effects of levosimendan on renal function in septic shock: a case–control study
por: Morelli, A, et al.
Publicado: (2009)

Levosimendan: experience of an adult ICU
por: Lippett, S, et al.
Publicado: (2006)

Effects of levosimendan on cellular metabolic alterations in patients with septic shock: a randomised controlled study
por: Meddeb, B, et al.
Publicado: (2015)

Levosimendan in cardiac surgery
por: Harjola, V, et al.
Publicado: (2004)

Utilization of levosimendan in the cardiac ICU: case series
por: Filipescu, D, et al.
Publicado: (2009)

Haemodynamic effects of levosimendan following cardiac surgery
por: Slezina, A, et al.
Publicado: (2009)

Levosimendan versus dobutamine in cardiac surgery
por: Delgado-Amaya, MD, et al.
Publicado: (2015)

Treatment of calcium channel blocker overdose with levosimendan
por: Sencan, A, et al.
Publicado: (2011)

Levosimendan in myocardial depression due to severe sepsis
por: Malik, M, et al.
Publicado: (2007)

Hemodynamic and volumetric response to levosimendan in critical care patients
por: Turani, F, et al.
Publicado: (2004)

Levosimendan in trauma patients with acute cardiac failure
por: Afonin, AN, et al.
Publicado: (2011)

Levosimendan versus dobutamine in Tako-tsubo cardiomyopathy
por: Righetti, FR, et al.
Publicado: (2013)

Use of levosimendan in myocardial dysfunction due to sepsis
por: Vaitsis, J, et al.
Publicado: (2009)

Levosimendan in critically ill adults: a utilisation review
por: Aron, J, et al.
Publicado: (2013)

Retrospective study of proarrhythmic effects of levosimendan during the therapy of heart failure
por: Zima, E, et al.
Publicado: (2007)

Combined effects of ivabradine with dobutamine or levosimendan in isolated perfused hearts
por: Konrad, D, et al.
Publicado: (2013)

Systemic and regional effects of levosimendan and arginine–vaopressine in endotoxin-treated rabbits
por: Kaskos, H, et al.
Publicado: (2004)

Levosimendan: use, cost-effectiveness and outcome in a tertiary cardiothoracic centre
por: Ranjan, A, et al.
Publicado: (2015)

Levosimendan use in critical care - a case series
por: Gibson, C, et al.
Publicado: (2015)

Hemodynamic effects of levosimendan in patients with low-output heart failure
por: Gharsallah, H, et al.
Publicado: (2008)

Influence of temperature on the cardiac action of dobutamine and levosimendan in isolated perfused hearts
por: Aldenhoff, U, et al.
Publicado: (2013)

Hemodynamic effects of the new calcium sensitiser levosimendan in cardiosurgical ICU patients
por: Iasonidou, C, et al.
Publicado: (2004)

Phenotypical analysis of peripheral human T lymphocytes in early sepsis
por: Nalos, M, et al.
Publicado: (2010)

Early experience with levosimendan in children with low-output syndrome after cardiac surgery
por: Galas, F, et al.
Publicado: (2008)

Levosimendan does not improve resuscitation success after hypovolemic cardiac arrest
por: Semenas, E, et al.
Publicado: (2008)

Levosimendan in the emergency department: a useful tool to improve cellular perfusion
por: Devia, G, et al.
Publicado: (2015)

Effect of levosimendan treatment on length of hospital and intensive care stay in the REVIVE I study
por: Johansson, S, et al.
Publicado: (2004)

Preoperative treatment with levosimendan helps to evaluate myocardial reserves in cardiosurgical patients with chronic heart failure
por: Eremenko, A, et al.
Publicado: (2015)

Is early ventricular dysfunction or dilatation associated with lower mortality rate in adult severe sepsis and septic shock? A meta-analysis
por: Huang, Stephen J, et al.
Publicado: (2013)

Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure
por: Mebazaa, A, et al.
Publicado: (2004)

Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study
por: Garratt, C, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_pknhub5o68nq6j9p35h7j6sbmm